| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.58B | $3.48B | $3.89B |
| YoY Revenue Growth % | +3.1% | -10.6% | — |
| Gross Profit | $731.0M | $705.0M | — |
| Gross Margin % | 20.4% | 20.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $365.8M | $332.8M | $308.0M |
| Operating Margin % | 10.2% | 9.6% | 7.9% |
| Net Income (GAAP) | $310.0M | $282.0M | $261.0M |
| EBITDA (Normalized) | $423.4M | $405.6M | $447.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $413.0M | $408.0M | $465.0M |
| Capital Expenditures (CapEx) | $72.0M | $91.0M | $174.9M |
| Free Cash Flow (FCF) | $341.0M | $317.0M | $290.1M |
| FCF Margin % | 9.5% | 9.1% | 7.5% |
| Return on Invested Capital (ROIC %) | 66.9% | 39.5% | 8.6% |
| Cash & Short-Term Equivalents | $177.0M | $125.0M | — |
| Total Debt (Short + Long Term) | $1.41B | $1.46B | $1.09B |
| Total Stockholders' Equity | -$802.0M | -$673.0M | $2.24B |